349 studies found for:    colorectal | Recruiting | Exclude Unknown | United States
Show Display Options
Rank Status Study
1 Recruiting Ohio Colorectal Cancer Prevention Initiative
Conditions: Lynch Syndrome;   Colorectal Cancer
Interventions: Genetic: LS tumor screening;   Genetic: Genetic testing;   Behavioral: Genetic Counseling;   Other: Biorepository;   Behavioral: Questionnaire
2 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
3 Recruiting Adjuvant Aflibercept for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Aflibercept
4 Recruiting RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Condition: Colorectal Cancer
Interventions: Drug: RAD011;   Drug: FOLFOX;   Drug: Bevacizumab
5 Recruiting Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
Condition: Colorectal Cancer
Interventions: Procedure: Colonoscopy;   Procedure: FIT
6 Recruiting Microbiome Test for the Detection of Colorectal Polyps and Cancer
Conditions: Colorectal Neoplasms;   Colorectal Cancer
Intervention:
7 Recruiting Decision Aid to Technologically Enhance Shared Decision Making
Condition: Colorectal Cancer
Intervention: Behavioral: Colorectal Web
8 Recruiting NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: NKTR-102;   Drug: irinotecan
9 Recruiting Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Rectal Cancer
Intervention: Drug: IMMU-130
10 Recruiting Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Capecitabine and aflibercept
11 Recruiting A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: PF-05212384;   Drug: irinotecan;   Drug: Cetuximab;   Drug: Irinotecan
12 Recruiting Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colorectal Cancer
Condition: Colorectal Cancers
Intervention: Biological: RENCA macrobeads
13 Recruiting Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Imprime PGG + cetuximab;   Drug: Cetuximab
14 Recruiting A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
Condition: Advanced Metastatic (Stage IV) Colorectal Cancer
Interventions: Drug: PledOx (2 µmol/kg);   Drug: PledOx (10 µmol/kg);   Drug: Placebo (0,9% NaCl)
15 Recruiting S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
Conditions: Anxiety Disorder;   Breast Cancer;   Cognitive/Functional Effects;   Colorectal Cancer;   Depression;   Fatigue;   Pain;   Psychosocial Effects of Cancer and Its Treatment;   Weight Changes
Interventions: Behavioral: behavioral dietary intervention;   Behavioral: exercise intervention;   Other: counseling intervention;   Procedure: quality-of-life assessment
16 Recruiting Phase 2A Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
Conditions: Metastatic Pancreatic Cancer;   Metastatic Colorectal Cancer
Intervention: Drug: NPC-1C/NEO-102
17 Recruiting Effectiveness of an mHealth Colorectal Cancer Screening Intervention
Condition: Colorectal Neoplasms
Interventions: Behavioral: mCRC intervention;   Behavioral: Healthy Lifestyles video
18 Recruiting A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss
Conditions: Metastatic Colorectal Cancer;   Cachexia;   Weight Loss
Interventions: Drug: MABp1;   Drug: Megestrol Acetate
19 Recruiting Study of Ruxolitinib in Colorectal Cancer Patients
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Ruxolitinib;   Drug: Regorafenib;   Drug: Placebo
20 Recruiting COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy
Condition: Colorectal Neoplasms
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years